Longeveron Inc - Class A

Research Longeveron Inc - Class A (LGVN) on Bullrun: market cap USD 22.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLGVN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 22.43M
• Financial periodFY2025
• RevenueUSD 1.20M
• Revenue growth-49.9%
• Net income-USD 22.70M
• Free cash flow-USD 18.89M
• Gross margin67.0%

Valuation Snapshot

latest market cap is USD 22.43M.

About Longeveron Inc - Class A

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome;

Frequently asked questions

What is Longeveron Inc - Class A's market cap?

Longeveron Inc - Class A's market capitalization is USD 22.43M.

What does Longeveron Inc - Class A do?

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.